|
|
Enron Mail |
Click here now to receive your FREE investor care package
on a New BioTech Stock in a Red-Hot Market! Centrex Inc. (CNEX - OTCBB) Centrex Inc. (CNEX - OTCBB) owns the exclusive rights to a bacteria-detection system developed at Los Alamos National Laboratory which allows for the detection of E. Coli. The company believes its proprietary technology can also be used for the detection of other bacterial and viral agents. Investment Highlights on Centrex Inc. (CNEX - OTCBB) New bioTech stock in red-hot market Company to market detection technology to - Postal Service - Military - State and City Health Departments - Airports Research contract with Los Alamos National Laboratory Technology is adaptable to detect a variety of organisms Grant application received from the federal government Other viral and bacterial agents being looked at for detection include - Salmonella typhi (typhoid) - Vibrio cholerae (cholera) - Yersinia pestis (plague) - Ebola Click here now to receive your FREE investor care package on a New BioTech Stock in a Red-Hot Market! Centrex Inc. (CNEX - OTCBB) Disclaimer: InvestFacts.com was paid $5,000 US by Corporate Profile of NY for this distribution. InvestFacts.com does not own stock in Centrex Inc. and is not affiliated with Centrex Inc.. The words and claims contained in this report are those of Corporate Profile of New York and not Investfacts.com. Investfacts.com has not attempted to verify any of the claims or statements contained herein. Investors must conduct their own due diligence. This notice shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state. Please check with your broker or with the company to determine whether these securities may be purchased or sold in your state of residence prior to effecting a transaction. The statements contained herein that are not statements of historical fact, including statements related to future financial expectations or industry growth expectations are "forward-looking statements" and involve risk and uncertainty. Actual results may differ due to numerous factors. See the company's filings with the Securities and Exchange Commission for details on such factors. --- You are currently subscribed to investfacts as: alewis@ect.enron.com To unsubscribe send a blank email to leave-investfacts-40195N@utarget.sparklist.com
|